Biologically Equivalent Substitutive Technology: What is Needed to Manufacture Pluripotent Stem Cells for Next-Generation Platforms for Discovery and Therapy
Author(s) -
Paul A. De Sousa
Publication year - 2013
Publication title -
regenerative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 63
eISSN - 1746-076X
pISSN - 1746-0751
DOI - 10.2217/rme.13.50
Subject(s) - regenerative medicine , induced pluripotent stem cell , stem cell , drug discovery , embryonic stem cell , biology , microbiology and biotechnology , bioinformatics , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom